Trial Profile
A Phase II, Randomized, Double Blind, Placebo-Controlled, Dose-Escalating Study to Assess the Pharmacokinetics and Pharmacodynamics of MTR105 in Cardiac Surgery Induced Hypotension Patients During Weaning Off Cardiopulmonary Bypass
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs MTR 104 (Primary)
- Indications Hypotension
- Focus Pharmacodynamics
- Sponsors Meditor Pharmaceuticals
- 03 Nov 2014 New trial record